CSI Market
Sign In | Register

Kuvatris Therapeutics Inc (PXMD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PXMD Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Kuvatris Therapeutics Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent0.44
Cash & Short-term Investments0.00
Accounts receivable0.00
Prepaid Expense And Other Assets Current0.38
Total Current Assets0.82
Other Assets, Noncurrent0.00
Prepaid Expense General And Administrative Current-
Prepaid Expense Contractors Current-
Total Assets0.82
Liabilities
Accounts Payable, Current AC2.15
Accrued Salaries, Current0.00
Notes Payable, Current NO0.00
Other Liabilities, Current0.11
Total Current Liabilities2.25
Total Long-term Debt0.00
Other liabilities, Noncurrent0.50
DeferredIncomeNoncurrent0.50
Accrued Liabilities Excluding Employee Related Liabilities Current0.11
Total Liabilities2.75
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock57.66
Retained Earnings / Accumulated Deficit-59.60
Other Equity0.00
Common Stockholder's Equity-1.93
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-1.93
Liabilities & Stockholder's Equity0.82
4 historic quarters locked

Sign in to unlock the full Kuvatris Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Kuvatris Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: January 14, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-002270

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.